Frederick Derosier, DO
Frederick Derosier, DO, is the Head of Fortrea's Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT). He has 22 years of experience in the pharma/biotech industry and 10 years of clinical practice in Internal Medicine. He has focused broadly on neurosciences and concentrated exclusively within rare diseases for more than 12 years.
His Phase I–IV expertise spans small molecules, combination products, biologics, RNA and gene therapies and he has experience leading global clinical development programs including clinical development strategy and planning, protocol development, regulatory and patient advocacy group interactions.
